Publications by authors named "Suzanne Marcotte"

Claim this Profile
D
Differences in Antiretroviral Adherence Behaviors, Treatment Success, and Eligibility for Long-Acting Injectable Treatment between Patients Who Acquired HIV in Childhood vs. Those Who Acquired It in Adolescence/Early Adulthood.
Anthony Marcellin, Valérie Martel-Laferrière, Anne-Geneviève Genest, Bertrand Lebouché, Suzanne Marcotte

J Pers Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practical clinical guide to counselling on and managing contraception, pre-conception planning, and menopause for women living with HIV.
Anna Cvetkovic, Elizabeth King, Lashanda Skerritt, Mona Loutfy, Alice Tseng, Suzanne Marcotte

J Assoc Med Microbiol Infect Dis Can· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of hyperconnected mobile modular production toward environmental and economic sustainability.
Charifa Fergani, Adiba El Bouzekri El Idrissi, Suzanne Marcotte, Abdelowahed Hajjaji

Environ Sci Pollut Res Int· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing concentrations of concomitant antiretrovirals by reducing etravirine doses: two case reports of complex drug-drug interactions.
Jean-Simon Denault, Jean-François Cabot, Hugo Langlois, Suzanne Marcotte, Nancy L Sheehan

Antivir Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of CHOP for treatment of diffuse large B-cell lymphoma with different combination antiretroviral therapy regimens: SCULPT study.
Alison Y J Wong, Suzanne Marcotte, Mathieu Laroche, Nancy L Sheehan, Vishal Kukreti

Antivir Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch from enfuvirtide to raltegravir in patients with undetectable viral load: efficacy and safety at 24 weeks in a Montreal cohort.
Annie Talbot, Nima Machouf, Réjean Thomas, Suzanne Marcotte, Rachel Therrien

J Acquir Immune Defic Syndr· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis